Fluorescence-based molecular imaging of in vivo release kinetics
基于荧光的体内释放动力学分子成像
基本信息
- 批准号:9429542
- 负责人:
- 金额:$ 6.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-01 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:AminesAnimal ModelAntibody titer measurementAntigensAttentionBehaviorBiocompatible MaterialsBiological AssayBloodBlood VesselsBovine Serum AlbuminBuffersChemistryClinicCollectionContraceptive AgentsContrast MediaConvectionDevice or Instrument DevelopmentDevicesDiabetes MellitusDropsDrug Delivery SystemsEmission-Computed TomographyEmulsionsEncapsulatedEstersEvaluationFluorescenceFluorescent ProbesFormulationGeometryGlycolatesHormone replacement therapyHydration statusHydrogelsImageImaging TechniquesImplantIn VitroKineticsLabelLibrariesLongitudinal StudiesMagnetic Resonance ImagingMaleimidesMalignant NeoplasmsMeasurementMeasuresMedical DeviceMethodsModelingMusNatureNoisePatientsPerformancePeriodicityPhotobleachingPhotonsPolymersPolymethyl MethacrylatePositronPositron-Emission TomographyPropertyProteinsRadiationRadioisotopesResearch PersonnelResearch TechnicsResolutionSafetySignal TransductionSiteSolventsSulfhydryl CompoundsSurfaceTechniquesTechnologyTetanus ToxoidTherapeuticTimeTissue EngineeringTissuesToxic effectTranslationsVaccinationVascular Endothelial Growth FactorsVascularizationWorkX-Ray Computed TomographyZirconiumarmbasebiodegradable polymerbiomaterial compatibilitycancer therapycaprolactoneclinically relevantcompliance behaviorcontrolled releasecostdensitydesignenzyme activityevaporationfluorescence imagingfluorophorehigh throughput screeningimaging modalityimplantable deviceimplantationimprovedin vivoin vivo optical imaginginterestmolecular imagingnon-invasive optical imagingpre-clinicalpre-clinical researchpreclinical evaluationpreclinical studyprematurequantumscaffoldsebacic acidsingle photon emission computed tomographysubcutaneoustherapeutic proteintherapy outcomevaccine delivery
项目摘要
PROJECT SUMMARY/ABSTRACT
Controlled release devices have the potential to improve therapeutic outcomes and patient compliance by
providing prolonged, localized delivery of drugs that maintain concentrations within the therapeutic window.
This approach has proven effective for a number of applications including hormone replacement therapy,1
contraceptives,2 and cancer therapy,3 yet the development of these devices for additional applications
continues to be hindered by an inability to easily study their behavior in the body. In vitro studies used to
assess therapeutic release from biodegradable polymer matrices or hydrogels are simple and inexpensive, but
frequently yield results that are not representative of in vivo release kinetics due to differences in hydration,
buffering, convection, and enzyme activity. Unfortunately, non-invasive preclinical imaging modalities that
could be used to study in vivo release such as magnetic resonance imaging (MRI), computed tomography
(CT), positron emission tomography (PET), and single-photon emission computed tomography (SPECT) are
expensive, low-throughput, and may require contrast agents whose release is not representative of the
therapeutic protein of interest.4 This project aims to validate and optimize a high-throughput technique for
studying in vivo release kinetics by tracking the depletion of fluorescently labeled proteins from controlled
release devices. This approach is faster, considerably less expensive, and potentially safer than existing
alternatives and also allows for the study of protein-specific kinetics which could differ greatly from model
proteins. In brief, this technique will use commercially available fluorescent labeling kits based on simple
maleimide or N-hydroxysuccinimide ester chemistry to label proteins via thiols or primary amines,
respectively.5 Fluorescently labeled proteins will then be encapsulated into polymeric devices (e.g.
microparticles, scaffolds) and implanted or injected in vivo. A longitudinal study consisting of periodic in vivo
fluorescence measurements will be performed to assess the amount of protein remaining in controlled release
devices over time. To validate the accuracy of this approach, PET, a low-throughput but highly quantitative
technique, will be performed in parallel using proteins that are double labeled with fluorophores and a
radioisotope. Correlation between the decrease in fluorescence and decrease in decay-corrected positron
emission will be used to demonstrate the quantitative relationship between protein content and fluorescent
signal. The robustness of fluorescence-based release will be evaluated using various fluorophores, materials,
device geometries, and implant sites in order to mitigate the influence of tissue absorbance, photobleaching,
and fluorophore pH-sensitivity that could otherwise negatively impact the accuracy of this approach.
项目总结/摘要
控制释放装置有可能通过以下方式改善治疗结果和患者依从性
从而提供维持治疗窗内浓度的药物的延长的局部递送。
这种方法已被证明对许多应用有效,包括激素替代疗法,1
避孕药,2和癌症治疗,3但这些设备的发展,为其他应用
由于无法轻松研究它们在体内的行为,体外研究用于
评估从可生物降解的聚合物基质或水凝胶的治疗释放是简单和廉价的,但
由于水合作用的差异经常产生不代表体内释放动力学的结果,
缓冲、对流和酶活性。不幸的是,
可用于研究体内释放,如磁共振成像(MRI)、计算机断层扫描
(CT)正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT)是
昂贵、低通量,并且可能需要造影剂,其释放不代表
该项目旨在验证和优化一种高通量技术,
通过跟踪来自受控的药物的荧光标记蛋白的消耗来研究体内释放动力学,
释放装置。这种方法比现有的方法更快,成本更低,而且可能更安全
替代方案,还允许研究蛋白质特异性动力学,这可能与模型差异很大
proteins.简而言之,该技术将使用市售的基于简单的荧光标记试剂盒。
马来酰亚胺或N-羟基琥珀酰亚胺酯化学通过硫醇或伯胺标记蛋白质,
然后将荧光标记的蛋白质包封到聚合物装置(例如,
微粒、支架)并在体内植入或注射。一项纵向研究,包括定期体内
将进行荧光测量以评估控释制剂中剩余的蛋白质的量
随着时间的推移。为了验证这种方法的准确性,PET是一种低通量但高定量的方法
技术,将平行进行使用蛋白质,是双标记的荧光团和
放射性同位素荧光减少与衰变校正正电子减少之间的相关性
发射将被用来证明蛋白质含量和荧光之间的定量关系
信号了将使用各种荧光团、材料,
装置几何形状和植入部位,以减轻组织吸收,光漂白,
和荧光团pH敏感性,否则会对该方法的准确性产生负面影响。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fabrication of fillable microparticles and other complex 3D microstructures.
制造可填充的微粒和其他复杂的3D微观结构。
- DOI:10.1126/science.aaf7447
- 发表时间:2017-09-15
- 期刊:
- 影响因子:0
- 作者:McHugh KJ;Nguyen TD;Linehan AR;Yang D;Behrens AM;Rose S;Tochka ZL;Tzeng SY;Norman JJ;Anselmo AC;Xu X;Tomasic S;Taylor MA;Lu J;Guarecuco R;Langer R;Jaklenec A
- 通讯作者:Jaklenec A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin James McHugh其他文献
Kevin James McHugh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kevin James McHugh', 18)}}的其他基金
Research Supplement to Promote Diversity: Carlos Torres (R03EB031495 Parent Award)
促进多样性的研究补充:Carlos Torres(R03EB031495 家长奖)
- 批准号:
10592146 - 财政年份:2022
- 资助金额:
$ 6.12万 - 项目类别:
Research Supplement to Promote Diversity: Belvi Bwela (R03EB031495 Parent Award)
促进多样性的研究补充:Belvi Bwela(R03EB031495 家长奖)
- 批准号:
10592142 - 财政年份:2022
- 资助金额:
$ 6.12万 - 项目类别:
Electrosprayed Core-Shell Microparticles as a Pulsatile Vaccine Delivery Platform
电喷雾核壳微粒作为脉冲疫苗输送平台
- 批准号:
10195135 - 财政年份:2021
- 资助金额:
$ 6.12万 - 项目类别:
Solvent Evaporator Equipment Supplement to R35GM143101
R35GM143101 溶剂蒸发器设备补充
- 批准号:
10799251 - 财政年份:2021
- 资助金额:
$ 6.12万 - 项目类别:
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
用于控制药代动力学的下一代肠外给药系统
- 批准号:
10277139 - 财政年份:2021
- 资助金额:
$ 6.12万 - 项目类别:
Electrosprayed Core-Shell Microparticles as a Pulsatile Vaccine Delivery Platform
电喷雾核壳微粒作为脉冲疫苗输送平台
- 批准号:
10372138 - 财政年份:2021
- 资助金额:
$ 6.12万 - 项目类别:
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
用于控制药代动力学的下一代肠外给药系统
- 批准号:
10890222 - 财政年份:2021
- 资助金额:
$ 6.12万 - 项目类别:
Research Supplement to Promote Diversity: Mei-Li Laracuente (1R35GM143101 Parent Award)
促进多样性的研究补充:Mei-Li Laracuente(1R35GM143101家长奖)
- 批准号:
10631614 - 财政年份:2021
- 资助金额:
$ 6.12万 - 项目类别:
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
用于控制药代动力学的下一代肠外给药系统
- 批准号:
10488240 - 财政年份:2021
- 资助金额:
$ 6.12万 - 项目类别:
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
用于控制药代动力学的下一代肠外给药系统
- 批准号:
10667652 - 财政年份:2021
- 资助金额:
$ 6.12万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists